2018 Vs 2017 1. Revenue 1.1 Brokerage fees The Company’s brokerage fees in 3Q2018 were Baht 211 million, a decrease of 8% from 3Q2017, mainly due to a decrease in brokerage fees from retail clients. 1.2
expenses in FY2020/21 shown a significant decrease of Baht 46.3 million as compared to FY2019/20. The continuous cost reduction activities and enhanced austerity drive are the main reasons for the savings to
ended March 31, 2020. The period-on-period decrease in finance costs was because of a loan payment. โรงพยาบาลราชพฤกษ ์ บริษทั โรงพยาบาลราชพฤกษ ์จ ากดั (มหาชน) Ratchaphruek Hospital Public Company Limited
Engineering Public Company Limited (“the Company”) would like to report the operating result according to the Company’s consolidated financial statement of the Company and its subsidiary for the first quarter
Stock Exchange of Thailand Ekachai Medical Care Public Company Limited (the “Company”) would like to clarify on the operating results for the Third quarter of 2019 at the end of 30th September 2019 as
profit of THB 64 million , and other operating activities of THB 827 million which attributable to a decrease from accounts receivable and inventory; 2) Cash flow spent for investing activities of THB 45
June 30, 2016 and the six-month period ended June 30, 2017, respectively. The figures represent a period-on-period decrease of 2.51% due mainly to an unusual high of patients from influenza epidemics in
zone increased from movement sold to EGR Australia to EGR Europe as delivery country. Gross profit margin decreased 5% duted to sold OEM project that high gross profit margin decrease, gross profit of
to remain fragile as overall purchasing power has not yet recovered, and household debt remains at a high level. The operating result of the Company in this quarter is still in line with the plan
Company and subsidiaries as follows: S&P Syndicate PCL and subsidiaries operating performance for 2nd quarter Ending 30 Jun 2019 Revenue from Sales and Services In the second quarter of year 2019, the